UPDATED 20.02.2014 09:47

Organised cervical cancer screening programme in the Uusimaa and Helsinki health care districts in Finland in the invitation year 1996. Numbers and percentage distribution of primary screening test results, referrals for further examinations, and histological diagnosis of the cervix uteri.

Screening Screened Referral Histological diagnosis
test     Invasive
carcinoma
Microinvasive
carcinoma
Carcinoma
in situ
Dysplasia
gravis
Dysplasia
moderata
Dysplasia
levis
Other or
normal
  n n % n % n % n % n % n % n % n %
Pap test1 47686 462 0.97 5 0.01 2 0.00 13 0.03 57 0.12 63 0.13 53 0.11 269 0.56
I 43847 1 - - - - - - - - - - - - - 1 -
II 3516 138 0.29 1 - - - - - 4 0.01 4 0.01 20 0.04 109 0.23
III 285 285 0.60 - - - - 8 0.02 37 0.08 52 0.11 33 0.07 155 0.33
IV 38 38 0.08 4 0.01 2 - 5 0.01 16 0.03 7 0.01 - - 4 0.01
V - - - - - - - - - - - - - - - - -
Inadequate - - - - - - - - - - - - - - - - -
Unknown - - - - - - - - - - - - - - - - -
HPV test - - - - - - - - - - - - - - - - -
Negative1 - - - - - - - - - - - - - - - - -
Positive2 - - - - - - - - - - - - - - - - -
Total 47686 462 0.97 5 0.01 2 0.00 13 0.03 57 0.12 63 0.13 53 0.11 269 0.56

1 Women with Papanicolaou class I or II negative HPV test are not referred for further examinations unless repeated cytology or other results are suggestive of cancer.
2 Women whose HPV test is positive are referred for further examinations on the basis of cytology or a repeatedly positive result.